Literature DB >> 25359301

The risk of breast cancer associated with specific patterns of migraine history.

Sarah J Lowry1, Kathleen E Malone, Kara L Cushing-Haugen, Christopher I Li.   

Abstract

PURPOSE: Studies have suggested that a history of migraines may be associated with a lower risk of some types of breast cancer, though biological mechanisms are unclear. Identifying specific characteristics of migraines which are most strongly associated with breast cancer risk could improve our understanding of this relationship.
METHODS: We ascertained specific characteristics of women's migraine histories (severity, timing features, and presence of migraine aura). We used polytomous logistic regression to estimate the risk of ER+ ductal, ER- ductal, ER+ lobular, and ER+ ductal-lobular breast cancer associated with self-reported characteristics of migraine history. A total of 715 breast cancer cases (276 ER+ ductal, 46 ER- ductal, 191 ER+ lobular, and 202 ER+ ductal-lobular) and 376 controls ages 55-74 years were included in this population-based case-control study.
RESULTS: Compared to women without a migraine history, women with a >30-year history of migraines had a 60 % (95 % CI 0.2-0.6) lower risk of ER+ ductal breast cancer; those who had their first migraine before age 20 had 50 % lower risks of ER+ ductal and ER+ lobular breast cancer (both 95 % CIs 0.3-0.9), and women who experienced migraine with aura had 30 % (95 % CI 0.5-0.98) and 40 % (95 % CI 0.4-0.9) lower risks of ER+ ductal and ER+ lobular breast cancer, respectively.
CONCLUSION: The lower risk of ER+ breast cancer associated with migraine appears to be limited to those women with early onset or long duration of migraine history, or those who experienced migraine with aura. This expands our understanding of the relationship between migraine and breast cancer and provides additional insight into potential underlying biological mechanisms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25359301      PMCID: PMC4283805          DOI: 10.1007/s10552-014-0479-y

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  28 in total

Review 1.  Migraine genes and the relation to gender.

Authors:  Reinald Shyti; Boukje de Vries; Arn van den Maagdenberg
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

Review 2.  Alcohol consumption and the risk of breast cancer.

Authors:  Gloria D Coronado; Jeannette Beasley; Jennifer Livaudais
Journal:  Salud Publica Mex       Date:  2011 Sep-Oct

3.  Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.

Authors:  Christopher I Li; Rowan T Chlebowski; Matthew Freiberg; Karen C Johnson; Lewis Kuller; Dorothy Lane; Lawrence Lessin; Mary Jo O'Sullivan; Jean Wactawski-Wende; Shagufta Yasmeen; Ross Prentice
Journal:  J Natl Cancer Inst       Date:  2010-08-23       Impact factor: 13.506

4.  Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women.

Authors:  Geoffrey C Kabat; Mimi Kim; Amanda I Phipps; Christopher I Li; Catherine R Messina; Jean Wactawski-Wende; Lewis Kuller; Michael S Simon; Shagufta Yasmeen; Sylvia Wassertheil-Smoller; Thomas E Rohan
Journal:  Cancer Causes Control       Date:  2011-03-01       Impact factor: 2.506

5.  Oral contraceptives in migraine therapy.

Authors:  Gianni Allais; Ilaria Castagnoli Gabellari; Cristina De Lorenzo; Ornella Mana; Chiara Benedetto
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

Review 6.  Migraine: a disorder of brain excitatory-inhibitory balance?

Authors:  Dania Vecchia; Daniela Pietrobon
Journal:  Trends Neurosci       Date:  2012-05-24       Impact factor: 13.837

7.  Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women.

Authors:  Christopher I Li; Robert W Mathes; Kathleen E Malone; Janet R Daling; Leslie Bernstein; Polly A Marchbanks; Brian L Strom; Michael S Simon; Michael F Press; Dennis Deapen; Ronald T Burkman; Suzanne G Folger; Jill A McDonald; Robert Spirtas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-07       Impact factor: 4.254

8.  Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat.

Authors:  Virginie Chauvel; Eniko Vamos; Arpad Pardutz; Laszlo Vecsei; Jean Schoenen; Sylvie Multon
Journal:  Exp Neurol       Date:  2012-05-14       Impact factor: 5.330

9.  Migraine history and breast cancer risk among postmenopausal women.

Authors:  Christopher I Li; Robert W Mathes; Elizabeth C Bluhm; Bette Caan; Mary F Cavanagh; Rowan T Chlebowski; Yvonne Michael; Mary Jo O'Sullivan; Marcia L Stefanick; Ross Prentice
Journal:  J Clin Oncol       Date:  2010-01-25       Impact factor: 44.544

Review 10.  Migraine in women: the role of hormones and their impact on vascular diseases.

Authors:  Simona Sacco; Silvia Ricci; Diana Degan; Antonio Carolei
Journal:  J Headache Pain       Date:  2012-02-26       Impact factor: 7.277

View more
  4 in total

1.  A pilot analysis of headache disorders in breast cancer patients.

Authors:  Rita De Sanctis; Alessandro Viganò; Sebastiano Pindilli; Rosalba Torrisi; Armando Santoro
Journal:  Neurol Sci       Date:  2021-11-24       Impact factor: 3.830

Review 2.  Migraine and breast cancer risk: a meta-analysis of observational studies based on MOOSE compliant.

Authors:  Xiujuan Wu; Minghao Wang; Shifei Li; Yi Zhang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

3.  The association between migraine and breast cancer risk: A systematic review and meta-analysis.

Authors:  Elahe Hesari; Mozhgan Ahmadinezhad; Maedeh Arshadi; Hosein Azizi; Farzad Khodamoradi
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

4.  Migraine and possible etiologic heterogeneity for hormone-receptor-negative breast cancer.

Authors:  Min Shi; Lisa A DeRoo; Dale P Sandler; Clarice R Weinberg
Journal:  Sci Rep       Date:  2015-10-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.